<DOC>
	<DOCNO>NCT00829543</DOCNO>
	<brief_summary>This study design evaluate efficacy safety guide-free sacroiliac joint ( SIJ ) injection refractory sacroiliac pain due spondyloarthropathies .</brief_summary>
	<brief_title>Unguided Sacroiliac Injection : Effect Refractory Buttock Pain Patients With Spondyloarthropathies</brief_title>
	<detailed_description>A 20 week open-label clinical trial study 35 patient , different subtypes spondyloarthropathies , conduct In spondyloarthropathy 's patient refractory inflammatory buttock pain ( fulfil inclusion criterion ) , perform outpatient guide-free sacroiliac injection triamcinolone acetonide 40 mg joint . Patient ( pain , stiffness , sleep disturbance ) Clinician assessment ( sacroiliac tenderness , Finger floor Schober test ) record baseline every 4 week end study . MRI score sacroiliac joint record accord Spondyloarthritis Research Consortium Canada ( SPARCC ) magnetic resonance imaging ( MRI ) index score inflammatory lesion sacroiliac joint , baseline end study .</detailed_description>
	<mesh_term>Spondylarthropathies</mesh_term>
	<mesh_term>Spondylarthritis</mesh_term>
	<criteria>Patients fulfill European Spondylarthropathy Study Group criteria SpA . 1 . The presence inflammatory buttock pain least 4 month ( typical night pain morning stiffness ) despite receive NSAIDs , corticosteroid DMARDs ( Disease Modifying AntiRheumatic Drugs ) : methotrexate , sulfasalazin azathioprine . 2 . Tenderness sacroiliac joint : pain sacroiliac sulcus 45 kg/cm2 direct pressure . 1 . Spinal infection ( Brucellosis ) . 2 . Local infection site injection . 3 . Sacroiliac ankylosis base pelvic XRay ( sacroilitis grade IV ) . 4 . Patients receive anti TNF , corticosteroid pulse investigational drug 4 month .</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>Spodyloarthropathy</keyword>
	<keyword>Guide-free sacroiliac injection</keyword>
</DOC>